A new study in the Canadian Medical Association Journal with health economist Steve Morgan as lead author argues a national universal care drug program would not result in substantial tax increases. It seems the time is ripe to finally complete our universal system of public healthcare coverage by adding a national public drug plan. If anything, these cautions should serve as guideposts to make sure a new national drug plan is not only effective but also designed in a fiscally sustainable manner.
The federal government plays a vital role in pharmaceutical drug regulation. We have many reasons to be proud of the systems for drug safety already in place in Canada. Yet there's room for significant improvement. Canadians deserve safe, effective, accessible and reliable pharmaceutical drugs when they need them. The only way to do this is through perpetually improved systems framed by transparency and openness.
Generally speaking, steroid users are not impressionable youth--they are young adults fully capable of making informed decisions about their own health. Steroid users are not devious cheaters--they are not involved with organized sport and are not bound by the rules of any sporting body. Steroid users are not less intelligent--they are professionals with more than average education. And steroid users bear little resemblance to addicts--they are seeking to improve their health, not feeding an addiction.
In a public healthcare system, too often system failures end up as fodder for Question Period battles rather than impetus for learning. When investments have been made in new models of health service funding and delivery that don't work out, it can be difficult to proclaim failure as a means to move toward success.
Employers want their drug plans to be as competitive as those offered by other employers. So what happens when the norm is to cover all new drugs at any cost, even if the drugs do not provide additional therapeutic value? Well, the end result is that everyone buys "generous" plans instead of increasing employee compensation. Everyone we spoke with agrees about the need to educate employees and employers alike. And in fact, everyone agrees (even insurers) that exorbitant drug costs are a big issue for Canadians.
Last week in Berlin more than 15 countries pledged over US$7.5 billion to buy vaccines for the children of the world's poorest countries for the next five years. While this is great news for the millions of children living in the 73 countries supported by Gavi, there were other big winners: the pharmaceutical companies that benefit from the soaring vaccine prices they charge for vaccines worldwide.
Although advertising of prescription medicines to the public is generally banned in Canada on public health grounds, shifts in administrative policy have allowed two types of ads since late 2000: "reminder" ads that mention a brand name, but make no health claims; and "help-seeking" ads that mention a condition, but do not state a brand or company name. We have identified six main weaknesses in how Health Canada regulates this advertising.
When patients get into trouble with highly addictive pain medications, their family physicians may not know where to refer them for help. To make matters worse, the prescribing habits of some physicians -- such as giving too high a dose of a drug -- can contribute to patients becoming addicted to painkillers.
Aside from self-love, there is another self-healing method you can try -- taking driving courses. This actually works a little bit like therapy since you are essentially asking yourself to face one of your greatest fears, which is driving. By having your driving instructor walk you through driving procedures, you may gain a clearer sense of control and the environment around you whenever you drive.
The Liberal government of New Brunswick appears to be stepping back from the brink of mandatory prescription drug insurance. And so they should. The drug plan chosen by the Conservatives was designed on a false premise: that the private sector can better manage things than government can. In many sectors, that might be true. But not in health care.
Rather than placing a tax on health needs -- as income-based drug plans do -- Ontario should consider a more positive road to universal pharmacare. Specifically, it should consider tax financing a universal drug benefit program that would give non-seniors the same coverage elderly residents enjoy today.
Last week, MPs debated Bill C-2 -- an Act to Amend the Controlled Drugs and Substances Act. The primary purpose of the bill is to obstruct the establishment of safe injection sites in Canada, despite over a decade of successful harm reduction at Vancouver's Insite. This is just one example of how politicians of all stripes get drug policy wrong.
Dr. Mel Borins wants to you to be healthy and he wants you equipped with more than just your family doctor's orders. A family physician and associate professor of medicine at the University of Toronto, Borins is a leading expert in health and wellness who has advocated evidence-based, alternative medicine for decades.
A lot of people who end up committing terrible crimes belong in jails -- not mental hospitals. Studies show the majority of people with mental illness are not violent and in fact are more likely to be a victim of a violent crime then commit one. Yes, some people with mental illness commit violent crimes but the majority of people who commit these same crimes are perfectly sane.
Better pharmacare for all Canadians will be difficult to achieve without the federal government at the table. The government of Canada could lead on this issue in a way that no single province or territory can do, by supporting the development of a single national list of drugs to be covered for all Canadians and by harnessing the purchasing power of the whole nation to get the best possible bang for our buck.
A 2013 EKOS poll showed that 78 per cent of Canadians are in favour of establishing a universal pharmacare program in Canada. In spite of self-serving lobby groups who insist that the current system is working well and should not be reformed, establishing a national drug plan is the best thing to do for patients, for employers, for employees, for taxpayers, and for the Canadian economy.
Ask any avid drug user the difference between 'molly' and 'ecstasy' and they will most likely tell you that 'molly is pure MDMA' and ecstasy was more known to be cut with other substances. In reality, this couldn't be further from the truth. And herein lies the problem. Unless you are an accomplished chemist, 'pure' MDMA is a myth.
Well, we've been having some interesting family discussions over dinner recently. Topics have included: marijuana, driver reaction time after consuming alcohol, how nicotine stains your fingers; the intense pain caused by Tasering; bras and body hair. One night, we even examined diagrams of male and female reproductive organs.